Concepts (148)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Neoplasms | 21 | 2021 | 1645 | 1.880 |
Why?
|
| Smoking | 10 | 2020 | 1045 | 1.410 |
Why?
|
| Genome-Wide Association Study | 14 | 2019 | 1684 | 1.280 |
Why?
|
| Genetic Predisposition to Disease | 19 | 2021 | 3153 | 0.850 |
Why?
|
| Polymorphism, Single Nucleotide | 13 | 2019 | 2634 | 0.850 |
Why?
|
| Adenocarcinoma | 6 | 2018 | 1022 | 0.630 |
Why?
|
| Genotype | 7 | 2018 | 2556 | 0.530 |
Why?
|
| Chromosomes, Human, Pair 15 | 5 | 2018 | 160 | 0.500 |
Why?
|
| Principal Component Analysis | 1 | 2016 | 142 | 0.490 |
Why?
|
| RNA Splice Sites | 1 | 2015 | 89 | 0.480 |
Why?
|
| Genetics, Population | 1 | 2016 | 188 | 0.480 |
Why?
|
| Introns | 1 | 2015 | 299 | 0.460 |
Why?
|
| Software | 2 | 2016 | 683 | 0.450 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 350 | 0.450 |
Why?
|
| Sequence Analysis, RNA | 2 | 2017 | 371 | 0.440 |
Why?
|
| Alternative Splicing | 1 | 2015 | 348 | 0.420 |
Why?
|
| Genetic Loci | 5 | 2015 | 339 | 0.360 |
Why?
|
| Neoplasm Proteins | 1 | 2015 | 669 | 0.360 |
Why?
|
| Chromosomes, Human, Pair 6 | 3 | 2021 | 142 | 0.340 |
Why?
|
| Case-Control Studies | 11 | 2019 | 3281 | 0.320 |
Why?
|
| Genetic Linkage | 3 | 2021 | 453 | 0.320 |
Why?
|
| Algorithms | 1 | 2016 | 1619 | 0.310 |
Why?
|
| Chromosome Mapping | 5 | 2021 | 1079 | 0.300 |
Why?
|
| Genetic Variation | 4 | 2021 | 1497 | 0.300 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2015 | 1893 | 0.290 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2018 | 666 | 0.280 |
Why?
|
| Receptors, Nicotinic | 3 | 2014 | 154 | 0.280 |
Why?
|
| Chromosomes, Human, Pair 5 | 2 | 2019 | 120 | 0.270 |
Why?
|
| Phenotype | 2 | 2015 | 4256 | 0.270 |
Why?
|
| Chromosomes, Human, Pair 12 | 2 | 2019 | 94 | 0.250 |
Why?
|
| Haplotypes | 4 | 2021 | 521 | 0.240 |
Why?
|
| Models, Genetic | 1 | 2008 | 759 | 0.230 |
Why?
|
| Liver Cirrhosis, Biliary | 2 | 2015 | 74 | 0.220 |
Why?
|
| Bayes Theorem | 3 | 2016 | 284 | 0.210 |
Why?
|
| Lod Score | 4 | 2021 | 120 | 0.180 |
Why?
|
| Biomarkers, Tumor | 2 | 2021 | 1484 | 0.170 |
Why?
|
| Humans | 31 | 2021 | 124593 | 0.170 |
Why?
|
| RNA Polymerase III | 1 | 2019 | 39 | 0.170 |
Why?
|
| Gene Expression | 2 | 2017 | 1561 | 0.160 |
Why?
|
| Major Histocompatibility Complex | 1 | 2018 | 51 | 0.150 |
Why?
|
| Telomerase | 1 | 2019 | 160 | 0.150 |
Why?
|
| Caudate Nucleus | 1 | 2017 | 35 | 0.140 |
Why?
|
| Nerve Tissue Proteins | 2 | 2014 | 1111 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 7 | 2 | 2019 | 72 | 0.140 |
Why?
|
| Gene-Environment Interaction | 1 | 2018 | 121 | 0.140 |
Why?
|
| Behavior, Addictive | 1 | 2017 | 58 | 0.140 |
Why?
|
| Female | 22 | 2021 | 66482 | 0.130 |
Why?
|
| Scleroderma, Systemic | 1 | 2018 | 120 | 0.130 |
Why?
|
| Risk Factors | 8 | 2019 | 10270 | 0.130 |
Why?
|
| HapMap Project | 1 | 2016 | 13 | 0.130 |
Why?
|
| Neuroglia | 1 | 2017 | 201 | 0.120 |
Why?
|
| Molecular Sequence Annotation | 1 | 2015 | 149 | 0.120 |
Why?
|
| Arabidopsis | 1 | 2015 | 70 | 0.120 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 2014 | 57 | 0.110 |
Why?
|
| Male | 20 | 2021 | 61191 | 0.110 |
Why?
|
| Survival Analysis | 1 | 2017 | 1496 | 0.110 |
Why?
|
| Homeostasis | 1 | 2017 | 685 | 0.110 |
Why?
|
| Quantitative Trait Loci | 3 | 2019 | 288 | 0.100 |
Why?
|
| Exons | 1 | 2015 | 796 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2012 | 59 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2012 | 49 | 0.100 |
Why?
|
| Epistasis, Genetic | 1 | 2012 | 93 | 0.100 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2015 | 358 | 0.100 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2012 | 129 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2012 | 140 | 0.100 |
Why?
|
| Meta-Analysis as Topic | 1 | 2012 | 156 | 0.100 |
Why?
|
| RNA | 1 | 2015 | 570 | 0.090 |
Why?
|
| Middle Aged | 11 | 2020 | 26714 | 0.090 |
Why?
|
| Membrane Proteins | 1 | 2019 | 1533 | 0.090 |
Why?
|
| Polymorphism, Genetic | 1 | 2014 | 811 | 0.090 |
Why?
|
| Pedigree | 3 | 2021 | 1605 | 0.090 |
Why?
|
| Analysis of Variance | 1 | 2012 | 1014 | 0.090 |
Why?
|
| Drosophila melanogaster | 1 | 2015 | 770 | 0.080 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 882 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 4 | 2 | 2019 | 57 | 0.080 |
Why?
|
| Promoter Regions, Genetic | 1 | 2012 | 1327 | 0.080 |
Why?
|
| Mycosis Fungoides | 1 | 2008 | 14 | 0.080 |
Why?
|
| Transcriptome | 1 | 2015 | 952 | 0.080 |
Why?
|
| Medical History Taking | 2 | 2019 | 108 | 0.080 |
Why?
|
| Tobacco Use Disorder | 1 | 2009 | 89 | 0.080 |
Why?
|
| Likelihood Functions | 1 | 2008 | 113 | 0.070 |
Why?
|
| Amino Acid Substitution | 1 | 2009 | 393 | 0.070 |
Why?
|
| Genotyping Techniques | 2 | 2019 | 103 | 0.070 |
Why?
|
| Probability | 1 | 2008 | 320 | 0.070 |
Why?
|
| Prognosis | 4 | 2021 | 4625 | 0.070 |
Why?
|
| Siblings | 1 | 2008 | 197 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2017 | 3552 | 0.060 |
Why?
|
| Genetic Markers | 1 | 2008 | 604 | 0.060 |
Why?
|
| Aged | 6 | 2020 | 19703 | 0.060 |
Why?
|
| Models, Statistical | 1 | 2008 | 471 | 0.060 |
Why?
|
| HLA Antigens | 2 | 2018 | 244 | 0.060 |
Why?
|
| Gene Frequency | 2 | 2018 | 722 | 0.060 |
Why?
|
| Adult | 7 | 2020 | 29438 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2015 | 2498 | 0.050 |
Why?
|
| Neoplasms | 1 | 2016 | 2771 | 0.050 |
Why?
|
| Cohort Studies | 3 | 2018 | 4795 | 0.050 |
Why?
|
| Skin Neoplasms | 1 | 2008 | 808 | 0.050 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 13 | 1 | 2019 | 8 | 0.040 |
Why?
|
| Sialoglycoproteins | 1 | 2019 | 48 | 0.040 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2019 | 77 | 0.040 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2019 | 154 | 0.040 |
Why?
|
| Gene Ontology | 1 | 2018 | 47 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2018 | 106 | 0.040 |
Why?
|
| Europe | 1 | 2019 | 354 | 0.040 |
Why?
|
| Phosphoproteins | 1 | 2019 | 402 | 0.040 |
Why?
|
| Telomere Homeostasis | 1 | 2017 | 42 | 0.030 |
Why?
|
| Reward | 1 | 2017 | 110 | 0.030 |
Why?
|
| Family Health | 1 | 2017 | 258 | 0.030 |
Why?
|
| Alleles | 2 | 2012 | 1615 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2018 | 351 | 0.030 |
Why?
|
| Selection, Genetic | 1 | 2016 | 154 | 0.030 |
Why?
|
| Young Adult | 2 | 2020 | 9014 | 0.030 |
Why?
|
| Peptides | 1 | 2018 | 796 | 0.030 |
Why?
|
| Emotions | 1 | 2017 | 350 | 0.030 |
Why?
|
| Animals | 1 | 2015 | 34072 | 0.030 |
Why?
|
| Genome, Human | 1 | 2021 | 1273 | 0.030 |
Why?
|
| DNA Primers | 1 | 2015 | 657 | 0.030 |
Why?
|
| Germ-Line Mutation | 1 | 2015 | 332 | 0.030 |
Why?
|
| Carcinoma | 1 | 2014 | 286 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 778 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 2876 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2015 | 1254 | 0.020 |
Why?
|
| Lung | 1 | 2018 | 1491 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2020 | 3694 | 0.020 |
Why?
|
| Base Sequence | 1 | 2015 | 3090 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2015 | 876 | 0.020 |
Why?
|
| Exome | 1 | 2015 | 1034 | 0.020 |
Why?
|
| Prevalence | 1 | 2016 | 2445 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 3878 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 6533 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 1016 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2015 | 1758 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2008 | 302 | 0.020 |
Why?
|
| Age Distribution | 1 | 2008 | 414 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2008 | 587 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2016 | 3441 | 0.020 |
Why?
|
| Age of Onset | 1 | 2008 | 586 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2018 | 8189 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2017 | 4501 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2008 | 1248 | 0.010 |
Why?
|
| Infant | 1 | 2018 | 12468 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2009 | 2816 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2018 | 14009 | 0.010 |
Why?
|
| Adolescent | 1 | 2018 | 19279 | 0.010 |
Why?
|
| Texas | 1 | 2008 | 3583 | 0.010 |
Why?
|
| Child | 1 | 2018 | 24374 | 0.010 |
Why?
|
| Brain | 1 | 2009 | 2983 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2008 | 16314 | 0.010 |
Why?
|